Hallucinations in Parkinson's disease (Q34394271)

1 August 2017

title

Hallucinations in Parkinson's disease (English)

1 reference

1 August 2017

1 reference

1 reference

A D Korczyn

1

0 references

language of work or name

English

0 references

publication date

1 September 2001

1 reference

1 August 2017

1 reference

1 August 2017

volume

358

1 reference

1 August 2017

issue

9287

1 reference

1 August 2017

page(s)

1031-1032

1 reference

Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906230-4

7 January 2021

Visual hallucinations in Parkinson's disease: a review and phenomenological survey

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906230-4

7 January 2021

Prospective study of hallucinations and delusions in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906230-4

7 January 2021

Auditory hallucinations in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906230-4

7 January 2021

Dream phenomena induced by chronic levodopa therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906230-4

7 January 2021

Visual deficits related to dopamine deficiency in experimental animals and Parkinson's disease patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906230-4

7 January 2021

Risk factors for dementia, depression and psychosis in long-standing Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906230-4

7 January 2021

Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: a community-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906230-4

7 January 2021

Hallucinations, sleep fragmentation, and altered dream phenomena in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906230-4

7 January 2021

Hallucinations, REM sleep, and Parkinson's disease: a medical hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906230-4

7 January 2021

Ropinirole versus bromocriptine in the treatment of early Parkinson's disease: A 6-month interim report of a 3-year study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906230-4

7 January 2021

Intravenous levodopa in hallucinating Parkinson's disease patients: high-dose challenge does not precipitate hallucinations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906230-4

7 January 2021

Low-dose clozapine in the treatment of levodopa-induced mental disturbances in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906230-4

7 January 2021

Quetiapine for the treatment of drug-induced psychosis in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906230-4

7 January 2021

Basal forebrain neurons in the dementia of Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906230-4

7 January 2021

Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906230-4

7 January 2021

Early dopaminergic drug-induced hallucinations in parkinsonian patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906230-4

7 January 2021

10.1016/S0140-6736(01)06230-4

Identifiers

DOI

1 reference

1 August 2017

1 reference